Moreover, glutamine-starved GBM cells showed upregulation of glutamine synthetase (GS) that promotes the conversion of glutamate into glutamine [21]; this enzyme has been found to be highly expressed in GBM clinical samples [21], implying that tumor cells utilize this complementary pathway to obtain glutamine required for their growth. This evidence concerns the gene GLUL and neoplasm.